Adult-Use
Cannabis CEOs don’t need federal legalization to grow their businesses
The CEOs of nine of the biggest cannabis companies in the US and Canada don’t have high hopes for federal legalization in 2022, reports Insider.
msogang
10stories
30 Novlast updated
More in msogang
- Cultivation
Will Tilray snap up an MSO pre-legalization?
Tilray CEO Irwin Simon says the company is actively shopping for the right multi-state cannabis operator to forge a path into the US market.
- Adult-Use
Analysts say these Canadian weed stocks could rebound post-legalization
US Senate Majority Leader Schumer’s bill is unlikely to be passed, but it’s a good starting point for negotiations, said Owen Bennett, senior vice president of global tobacco and cannabis stocks at Jefferies Equity Research, on BNN Bloomberg.
- Cannabis Daily News
Jefferies is betting on these U.S. weed stocks
New York-based investment banking company Jefferies Group is initiating coverage of seven U.S. pot stocks — Curaleaf, Green Thumb, Trulieve, Cresco, Columbia Care, TerrAscend and Ayr Strategies — and upgraded them all to a “buy” rating, reports BNN Bloomberg.
- Uncategorized
Canadian ETFs are riding high — thanks to the US
In the last year, cannabis ETFs Purpose and Horizons have returned 157.42% and 136.36% respectively, which is significantly higher than big funds like the ARK Innovation ETF, according to Morningstar.
- Adult-Use
Wall Street picks MSOs over Canada
Despite good news like New York legalization and the SAFE banking act advancing, the cannabis capital market haven’t rebounded all the way, reports MarketWatch.
- Adult-Use
The ‘Wolf of Weed Street’ bets against Canada
Cannabis stock analyst Jason Spatafora, a.k.a. the Wolf of Weed Street, had harsh predictions for debt-strapped Canadian public companies banking on survival in the US.
